GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KRYS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Krystal Biotech Inc stock after losing 3.32%
(Updated on Apr 19, 2024)

Sell candidate since Apr 15, 2024 Loss -6.61% PDF

The Krystal Biotech Inc stock price fell by -3.32% on the last day (Friday, 19th Apr 2024) from $163.97 to $158.53. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.53% from a day low at $155.91 to a day high of $164.53. The price has fallen in 7 of the last 10 days and is down by -11.94% for this period. Volume has increased on the last day by 62 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 331 thousand shares were bought and sold for approximately $52.45 million.

Given the current short-term trend, the stock is expected to rise 70.29% during the next 3 months and, with a 90% probability hold a price between $269.96 and $326.82 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KRYS Signals & Forecast

There are few to no technical positive signals at the moment. The Krystal Biotech Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $169.36 and $172.61. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 08, 2024, and so far it has fallen -12.13%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Krystal Biotech Inc stock

Krystal Biotech Inc finds support from accumulated volume at $157.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $8.62 between high and low, or 5.53%. For the last week, the stock has had daily average volatility of 3.82%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KRYS) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Krystal Biotech Inc to open at $159.66, and during the day (based on 14 day Average True Range), to move between $151.69 and $165.37, which gives a possible trading interval of +/-$6.84 (+/-4.31%) up or down from last closing price. If Krystal Biotech Inc takes out the full calculated possible swing range there will be an estimated 8.63% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $157.00 (0.97%) than the resistance at $170.15 (7.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Krystal Biotech Inc stock A Buy?

The Krystal Biotech Inc stock holds several negative signals and despite the positive trend, we believe Krystal Biotech Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.227 Sell Candidate Unchanged

Predicted Opening Price for Krystal Biotech Inc of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$159.66 ( 0.710%) $158.53

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KRYS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 168.27 6.14 %
R2 164.98 4.07 %
R1 162.95 2.79 %
Current price: 158.53
Support S1 156.36 -1.37 %
S2 154.33 -2.65 %
S3 151.04 -4.72 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 171.84 8.40 %
R2 170.84 7.77 %
R1 170.15 7.33 %
Current price 158.53
Support S1 157.00 -0.97%
S2 130.37 -17.76%
S3 119.09 -24.88%

FAQ

What is the symbol for Krystal Biotech Inc Stock and on which exchange is it traded?
The symbol for Krystal Biotech Inc is KRYS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Krystal Biotech Inc Stock?
The Krystal Biotech Inc stock holds several negative signals and despite the positive trend, we believe Krystal Biotech Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Krystal Biotech Inc Stock?
Krystal Biotech Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Krystal Biotech Inc Stock.

What's the current price of Krystal Biotech Inc Stock?
As of the end of day on the 2024-04-19, the price of an Krystal Biotech Inc (KRYS) share was $158.53.

What is the 52-week high and low for Krystal Biotech Inc Stock?
The 52-week high for Krystal Biotech Inc Stock is $189.58 and the 52-week low is $82.09.

What is the market capitalization of Krystal Biotech Inc Stock?
As of the 2024-04-19, the market capitalization of Krystal Biotech Inc is 4.8B.

When is the next earnings date for Krystal Biotech Inc?
The upcoming earnings date for Krystal Biotech Inc is May 13, 2024.
Click to get the best stock tips daily for free!

About Krystal Biotech Inc

Krystal Biotech Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive con... KRYS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT